|
ZNF786 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.302400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.840800E-01 |
| Normal-vs-Stage2 |
6.609400E-01 |
| Normal-vs-Stage3 |
9.670800E-01 |
| Normal-vs-Stage4 |
3.960800E-01 |
| Stage1-vs-Stage2 |
6.957200E-01 |
| Stage1-vs-Stage3 |
9.592000E-01 |
| Stage1-vs-Stage4 |
4.568400E-01 |
| Stage2-vs-Stage3 |
7.268400E-01 |
| Stage2-vs-Stage4 |
7.113000E-01 |
| Stage3-vs-Stage4 |
4.835200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.726200E-01 |
| Normal-vs-AfricanAmerican |
2.798800E-01 |
| Normal-vs-Asian |
3.337200E-01 |
| Caucasian-vs-AfricanAmerican |
1.120350E-01 |
| Caucasian-vs-Asian |
6.459600E-01 |
| AfricanAmerican-vs-Asian |
2.526400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.997800E-01 |
| Normal-vs-Female |
1.149230E-01 |
| Male-vs-Female |
4.495600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.540000E-01 |
| Normal-vs-Extreme_Weight |
9.092200E-01 |
| Normal-vs-Obese |
9.371000E-01 |
| Normal-vs-Extreme_Obese |
6.756600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.063000E-01 |
| Normal_Weight-vs-Obese |
7.105800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.194200E-01 |
| Extreme_Weight-vs-Obese |
9.723200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.658000E-01 |
| Obese-vs-Extreme_Obese |
6.274600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.075200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.732180E-01 |
| Normal-vs-Age(61-80Yrs) |
6.299400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.986200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.004200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.443400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.937600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.883800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.432200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.042000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.315600E-02 |
| Normal-VS-Type2 PRCC |
1.456510E-03 |
| Normal-VS-KIRP CIMP |
3.040600E-01 |
| Normal-VS-Unclassified PRCC |
4.913400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.66919999623173E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.915500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.945600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.429190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.001400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.439380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.270500E-02 |
| Normal-vs-N1 |
4.275000E-01 |
| Normal-vs-N2 |
5.648200E-02 |
| N0-vs-N1 |
3.301600E-02 |
| N0-vs-N2 |
4.598200E-01 |
| N1-vs-N2 |
1.557810E-01 |
|
|
